Contents
Academic literature on the topic 'FRET en temps résolu'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'FRET en temps résolu.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "FRET en temps résolu"
Bazin, H., N. Gaborit, J. Vallague, C. Larbouret, E. Lopez-Crapez, A. Ho-Pun-Cheung, P. Garnero, and A. Pèlegrin. "R77 – Oral: Détection de l’oligomérisation des récepteurs de la famille HER par Transfert d’Énergie de Fluorescence en Temps Résolu (TR-FRET) : un nouveau biomarqueur potentiel de la réponse au traitement anti-HER." Bulletin du Cancer 97, no. 4 (October 2010): S45. http://dx.doi.org/10.1016/s0007-4551(15)30995-4.
Full textCraig, Béatrice. "Solder les comptes : les sources de crédits dans les magasins généraux ruraux de l’est canadien au milieu du XIXe siècle." Journal of the Canadian Historical Association 13, no. 1 (February 9, 2006): 23–47. http://dx.doi.org/10.7202/031152ar.
Full textTurgeon, A. "Détermination du schéma d'aménagement optimal d'une vallée pour des fins de production d'électricité." Revue des sciences de l'eau 1, no. 1-2 (April 12, 2005): 129–52. http://dx.doi.org/10.7202/705006ar.
Full textArago, François, and Michel Rochas. "Sur la prédiction du temps : Est-il possible dans l'état actuel de nos connaissances de prédire le temps qu'il fera à une époque et dans un lieu donné ? Peut-on espérer, en tous cas, que ce problème sera résolu un jour ? - Par François Arago (1786-1853) ; texte publié en 1858, réédité et introduit par Michel Rochas en 1994." La Météorologie 8, no. 5 (1994): 61. http://dx.doi.org/10.4267/2042/53403.
Full textKombienou, Pocoun Damè, Ismaël Imorou Toko, Gustave Dieudonné Dagbenonbakin, Guy Apollinaire Mensah, and Brice Augustin Sinsin. "Impacts socio-environnementaux des activités agricoles en zone de montagnes au Nord-Ouest de l’Atacora au Bénin." Journal of Applied Biosciences 145 (January 31, 2020): 14914–29. http://dx.doi.org/10.35759/jabs.145.7.
Full text"P163 Génotypage Complet Du Système Duffy Par Pcr En Temps Réel (FRET) : Une Méthode Rapide Et Fiable Pour Répondre À L'urgence Transfusionnelle." Transfusion Clinique et Biologique 12 (June 2005): S117. http://dx.doi.org/10.1016/s1246-7820(05)80723-2.
Full textSlavik, Richard S., Manish Khullar, Sean K. Gorman, Nicole Bruchet, Sarah Murray, Brett Hamilton, and Dawn Dalen. "Contribution of Pharmacy Practice Residents to Resolution of Drug Therapy Problems for Patients: RES-DTP Study." Canadian Journal of Hospital Pharmacy 72, no. 5 (October 21, 2019). http://dx.doi.org/10.4212/cjhp.v72i5.2928.
Full textDissertations / Theses on the topic "FRET en temps résolu"
Maurel, Damien. "Oligomérisation des récepteurs couplés aux protéines G : deux ou plus ? : application des technologies de FRET en temps résolu au cas du récepteur GABAb." Phd thesis, Université Montpellier I, 2006. http://tel.archives-ouvertes.fr/tel-00165100.
Full textAu cours de ce travail de thèse nous avons développé une approche de FRET en temps résolu permettant de mettre en évidence, à l'aide d'anticorps marqués, des interactions de sous-unités de RCPG à la surface de cellules vivantes. En choisissant le récepteur GABAB comme modèle d'étude, cette approche a permis de révéler l'homo- et l'hétérodimérisation de ce récepteur à la surface cellulaire. De plus, en condition de perméabilisation des cellules, l'oligomérisation de la sous-unité GABAB1 retenue dans les compartiments intracellulaires a pu être caractérisée par cette même approche.
Afin d'analyser plus précisément l'organisation du récepteur GABAB, nous avons mis au point une deuxième méthode permettant de marquer irréversiblement à l'aide de fluorophores les sous-unités GABAB1 et GABAB2 présentes à la surface cellulaire. La combinaison de cette méthode de marquage (SNAP-tag) avec une analyse de FRET en temps résolu a permis de caractériser l'organisation oligomérique de ce récepteur. Ainsi, le récepteur GABAB, connu pour être un hétérodimère obligatoire, semble capable de former des oligomères via la sous-unité GABAB1 qui représente un point de contact entre deux hétérodimères. Le rôle d'une telle organisation sur la fonction de ce récepteur reste toutefois indéterminé.
Devauges, Viviane. "Microscopie de fluorescence résolue en temps et en polarisation pour le suivi d’interactions protéiques en neurobiologie." Thesis, Paris 11, 2011. http://www.theses.fr/2011PA112315/document.
Full textIn the framework of this thesis, we have used FRET (Forster Resonance Energy Transfer) as a mechanism to follow the interaction of proteins from the plasma membrane to the cytoplasm of cells. To quantify FRET, we have chosen Fluorescence Lifetime Imaging Microscopy (FLIM) since this method is independent of the concentration and intensity of the fluorophores. To have a good axial resolution, a TIRFLIM set-up (Total Internal Reflection Fluorescence Lifetime Imaging Microscopy) was developed and this allowed us to perform wide-field imaging with sub-wavelength axial resolution. This set-up was calibrated and optimized in order to answer biological questions. Different approaches were tested in order to measure the penetration depth of the evanescent field and especially plasmonic surfaces were used to further enhance the axial resolution. Our set-up was dedicated to the study of the effect of cholesterol on the interaction between the Amyloid Precursor Protein (APP), a transmembrane protein involved in Alzheimer Disease, and one of its cleaving enzyme (BACE1). We performed a dynamic tracking of APP and BACE1 proximity under the effect of cholesterol, in HEK-293 cells and primary cultures of embryonic rat hippocampal neurons, thanks to our TIRFLIM set-up.Time-resolved fluorescence anisotropy has been implemented on our set-up. This has enabled us to measure the rotational correlation time of fluorophores and to investigate quantitatively different states of homodimerization of proteins involved in Alzheimer’s disease
Cottet, Martin. "Oligomérisation des récepteurs couplés au protéines G de la famille de la vasopressine et de l’ocytocine : mise en évidence dans les tissus natifs." Thesis, Montpellier 2, 2013. http://www.theses.fr/2013MON20030/document.
Full textG-protein coupled receptors form a very large family of transmembrane receptors. Numerous studies have shown that these receptors showed a tendency to interact and form oligomers. These structures are however the matter of great debate. Indeed, very few elements allow us to maintain that these oligomers could exist in native tissues, most studies being carried out in heterologous systems. We have therefore developed an approach based for one part on the use of fluorescent ligands to label receptors in their native environment, and on the other part on time-resolved FRET (Fluorescence Resonance Energy Transfer) by using lanthanide cryptates, more specifically Lumi4-Tb. We have thus been able to show and publish the existence of oxytocin receptor oligomers in the mammary gland. The protocol used for this study was also published and validated for the study of hetero-oligomers, more specifically between vasopressin V1a and V2 receptors. Following on our study of oligomers in native tissues, we have developed our own setup to perform time-resolved FRET microscopy. This setup is based on a wide field microscope to which we added a laser source for the pulsed excitation and a Multigate CCD camera for imaging. We are here presenting the first results as well as its validation for the use of multiple acceptor fluorophores with minimal bleed through from the Lumi4-Tb. Lastly, we propose a pharmacological model showing the use of bivalent ligands to study oligomer coupling
Bhuckory, Shashi. "Quantum dots and upconverting nanoparticles : Bioconjugation and time-resolved multiplexed FRET spectroscopy for cancer diagnostics." Thesis, Université Paris-Saclay (ComUE), 2016. http://www.theses.fr/2016SACLS447/document.
Full textCombining high sensitivity with simultaneous analysis of numerous biomarkers (multiplexing) is an essential requirement for significantly improving the field of biomedical diagnostics. Such progresses would allow earlier diagnosis, which is required for numerous diseases such as cancer or cardiac diseases. FRET-immunoassays are based on biomolecular recognition events that occur between biomarkers and two specific antibodies conjugated with different fluorophores. The spatial proximity of the two fluorophores can lead to Förster resonance energy transfer (FRET), which can be detected for biomarker quantification. To date, such assays are established using lanthanide complexes as FRET donors and fluorescence dyes as FRET acceptors. However, these assays do not provide sufficient multiplexing capability due to spectral overlap, when several acceptor dyes are used. This project aims at exploiting the exceptional photophysical properties of terbium complexes (Tb) and semiconductor quantum dots (QDs) to provide ultrasensitive multiplexed FRETimmunoassays. We also studied the optical and morphological properties of novel core and core/shell upconverting nanoparticles doped with ytterbium (Yb) and erbium (Er) ions as possible FRET-donors for biosensing
Wu, Yu-Tang. "Förster Resonance Energy Transfer Immunoassays Using Engineered Proteins for Breast Cancer Biomarker Detection." Thesis, Université Paris-Saclay (ComUE), 2018. http://www.theses.fr/2018SACLS340/document.
Full textEngineered affinity proteins have raised great interest due to their extremely small size compared to full length antibodies. Such small binding proteins have demonstrated many advantages such as quick biodistribution, good penetration into tumor tissue, and fast elimination from serum and nondiseased tissues. Thus, they are expected to be excellent alternatives to antibodies for clinical applications. This thesis focuses on the development of biosensors based on engineered antibodies and time-resolved Förster resonance energy transfer (FRET) through biological recognition of biomarkers. FRET-based immunoassays are established using terbium complexes (Tb) as FRET donors and semiconductor quantum dots (QDs) as FRET acceptors. The exceptional photophysical properties of the Tb-QD FRET pair allow for ultrasensitive quantitative biosensing. Single-domain antibodies (sdAb) and small engineered scaffold antibodies (ADAPT) are used to investigate different antibody-conjugation strategies for quantifying human epidermal growth factor receptors (EGFR, HER2) as clinical biomarkers. This work can be considered as a prerequisite to implementing QDs into applied clinical diagnostics
Blandin, Pierre. "Développement instrumental pour la microscopie de fluorescence résolue en temps : applications biomédicales." Phd thesis, Université Paris Sud - Paris XI, 2008. http://tel.archives-ouvertes.fr/tel-00376116.
Full textCe travail s'est articulé autour de trois axes principaux : l'étude et le développement d'un dispositif d'excitation de la fluorescence basé sur un oscillateur laser solide picoseconde dont le spectre est élargi par effets non linéaires dans des fibres optiques microstructurées ; le développement et la caractérisation d'un dispositif de microscopie de fluorescence par onde évanescente (TIRF) couplé à une détection résolue en temps en plein champ ; et l'application de ce dispositif à l'étude d'un précurseur membranaire du peptide amyloïde impliqué dans la maladie d'Alzheimer.
Xu, Jingyue. "Sensitive and mutiplexed microRNA quantification using amplified time-gated Förster resonance energy transfer." Thesis, université Paris-Saclay, 2020. http://www.theses.fr/2020UPASS137.
Full textAs new generation of biomarkers, microRNAs are associated with many cancers and diseases, which has led to a great demand for developing clinical miRNA diagnostic methods. Isothermal amplification technologies, such as rolling circle amplification and catalytic hairpin assembly, have emerged as powerful methods for highly rapid, specific and sensitive microRNA assays. This thesis focuses on developing microRNA biosensors based on isothermal amplification technologies and time-resolved Förster resonance energy transfer from lanthanide complexes to organic dyes or quantum dots. The proposed amplified microRNA biosensors have very low limits of detections, and are applied to human clinical samples, successfully revealing the relevance for cancer diagnostics. As simultaneous detection of multiple microRNAs is highly demanded, temporal multiplexed detection of microRNAs is also realized based on distinguishable excited-state lifetimes of Tb complexes and dyes. Moreover, the amplified microRNA nanosensor based on Tb-to-quantum dots FRET demonstrated the possibility of spectral multiplexed detection of microRNAs with high sensitivity and selectivity
Devauges, Viviane. "Microscopie de fluorescence résolue en temps et en polarisation pour le suivi d'interactions protéiques en neurobiologie." Phd thesis, Université Paris Sud - Paris XI, 2011. http://tel.archives-ouvertes.fr/tel-00816666.
Full textMonnier, Carine. "Analyse de l'activation du récepteur GABA-B : une machinerie complexe de la transmission synaptique." Montpellier 2, 2009. http://www.theses.fr/2009MON20153.
Full textG-protein coupled receptors (GPCRs) constitute the largest family of membrane receptors, and the target of more than 25% of drugs on the market. Understanding the molecular mechanisms of the activation of such oligomeric complexes is crucial to develop more potent drugs. The metabotropic γ-aminobutyric acid receptor (GABA-B) is activated by the main inhibitory neurotransmitter of the central nervous system (GABA). It plays an important role in brain functions and as such, it is a potential therapeutic target for the treatment of various neurologic and psychiatric disorders (anxiety, epilepsy or drug addiction). The GABA-B receptor is an obligatory heterodimer composed of two subunits, GB1 and GB2, each of them possessing an extracellular domain called Venus flytrap (VFT) and a seven transmembrane domain (7TM) common to all GPCRs. The VFT of GB1 contains the GABA binding site whereas 7TM domain of GB2, where the positive allosteric modulators bind, is responsible for G-protein activation. My doctoral research project had two main objectives. The first one was to better understand the molecular mechanism underlying the activation of GABA-B receptor. We first demonstrated the importance of the relative movement of GB1 and GB2 VFT domains in the activation, using a « glycan wedge scanning » approach. In addition, we showed a direct transactivation between the two 7TM that is a key step in GABA-B activation. The second objective was the development of a sensor to monitor the GABA-B receptor activation at the cell surface of living cells. This sensor, based on GABA-B receptor conformational changes during activation used new fluorescent tools compatible with time-resolved FRET experiments. To this aim, we set up an orthogonal labelling between an ACP-tag inserted in a loop of one subunit and a Snap-tag fused to the other. This sensor of GABA-B activation should lead to the development of a medium or high throughput screening of specific GABA-B molecules
Scholler, Pauline. "De la compréhension de la dynamique structurale des récepteurs mGlu au développement de nouveaux agents d’intérêt thérapeutique." Thesis, Montpellier 1, 2013. http://www.theses.fr/2013MON13519.
Full textGlutamate is the main excitatory neurotransmitter in the central nervous system. It notably acts on eight metabotropic glutamate receptors (mGluR), which are G protein coupled receptor responsible for the modulation of synaptic transmission. mGluRs are promising pharmacological targets to treat neurological, psychiatric or neurodegenerative diseases such as depression, schizophrenia or Parkinson's disease. Unfortunately, so far, no drug acting at mGluR is accessible to patients, but several molecules are in clinical trials. The main objective of my thesis has been the study of the structural dynamics of mGluR, for which the molecular mechanism allowing activation are still poorly understood. These receptors are known to form constitutive dimers, with each subunit composed of a large extracellular domain which bind glutamate and a transmembrane domain responsible for G protein activation and where synthetic allosteric modulators bind. A key step in the activation process could be the relative reorientation of the two extracellular domains in the dimer upon glutamate binding. We first developed an orthogonal labeling method of each mGlu subunits by fusion with a suicide enzyme (SNAP-/CLIP-tag) that we combined with time-resolved Förster resonance energy transfer measurements to show that in a heterologous system, mGlu subunits can associate as strict and functional heterodimers. Our experiments also revealed a specific association pattern: mGlu subunits from group I, mGlu1 and mGlu5, can associate with each other, but not with those from group II and III, which can also associate with each other. Then we improved the technology to develop the first conformational sensor to monitor mGluR activation. We were able to monitor in real time in live cells the conformational changes occurring in the mGlu receptor upon activation, and we proved that the variation in FRET signal is correlated with the activation state of the receptor. This allowed us to confirm the activation model proposed based on the crystal structures of the isolated extracellular domains, which consist of a relative movement of the dimer extracellulair domains upon activation. Moreover, this sensor makes it possible to easily discriminate between full and partial agonists, and to better understand the allosteric mechanisms occurring in the mGluR (especially the action mode of positive and negative allosteric modulators binding in the transmembrane domain). This conformational sensor strategy was further applied to study the activation of other receptors (GPCR or tyrosine kinase receptors), and to develop screening assays compatible with high-throughput formats. Finally, we developed innovative ligands acting on mGluRs using single-domain antibodies from llamas. These activating ligands seem to bind to a new site on the surface of the receptor, offering new possibilities to develop better treatment acting at mGluRs